The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients
- Conditions
- Medication AdherenceStrokeOlder Adults
- Interventions
- Behavioral: Family based interventionBehavioral: Patient-based interventionOther: Routine counseling
- Registration Number
- NCT02842840
- Lead Sponsor
- Qazvin University Of Medical Sciences
- Brief Summary
Stroke is a major cause of morbidity and mortality, especially in low and middle income countries including Iran. Patients with recent stroke or TIA are at high risk for new vascular events. Several evidence based strategies in secondary prevention of stroke are available but frequently underused. The study is aimed to evaluate an intervention to improve patients with Stroke.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 405
- aged 65 years or older
- able to give informed consent
- recurrent stroke
- a diagnosis of subarachnoid haemorrhage
- significant impairments precluding participation - inability to give informed consent
- another condition likely to impact their participation in the trial (e.g. life-threatening condition other than cardiovascular disease)
- expected discharge to hospital/nursing home setting
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Family based intervention Family based intervention Patients and their families will receive a series of educational/motivational interventions. Patients based intervention Patient-based intervention A multifaceted intervention program will use to improve adherence and clinical outcomes in Stroke patients. This intervention focus on behavioral treatment in the patients. Routine counseling Routine counseling All participants of the study in both group receive the Standard Care. Usually, patients in clinics receive a one-time session of brief advice to use medications regularly lasting approximately 30 minutes and deliver by nurse or physician. Some issues rise in this short session including coexisting diseases, the history of drug use, current disease and advice about the health risks of irregular medication use.
- Primary Outcome Measures
Name Time Method changes in low-density lipoprotein (LDL)-cholesterol level changes from baseline, 6 Months, 12 months and 18 months follow-up changes in Patient-reported Adherence Medication Adherence Rating Scale changes from baseline, 6 Months, 12 months and 18 months follow-up a self-report measure of adherence (Medication Adherence Report Scale \[MARS-5\]) will be used .
changes in blood pressure changes from baseline, 6 Months, 12 months and 18 months follow-up
- Secondary Outcome Measures
Name Time Method Changes in Coping Plan changes from baseline, 6 Months, 12 months and 18 months follow-up The coping plan is assessed by a self-reported questionnaire. It is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention
Changes in intention to medication adherence changes from baseline, 6 Months, 12 months and 18 months follow-up Changes in Action Plan changes from baseline, 6 Months, 12 months and 18 months follow-up The action plan is assessed by a self-reported questionnaire. it is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention
Changes in quality of life changes from baseline, 6 Months, 12 months and 18 months follow-up The Short Form (36) Health Survey is used to assess patient's quality of life
Changes in perceived behavioral control to medication adherence changes from baseline, 6 Months, 12 months and 18 months follow-up The perceived behavioral control to medication adherence is assessed through a self-report instrument
Changes in Self-monitoring to medication adherence changes from baseline, 6 Months, 12 months and 18 months follow-up The Self-monitoring to medication adherence is assessed through a self-report instrument
Changes in Illness Perceptions changes from baseline, 6 Months, 12 months and 18 months follow-up the Brief Illness Perception. Questionnaire (Brief IPQ) is used to assess patient's illness representation
Trial Locations
- Locations (3)
Qazvin University of Medical Sciences
🇮🇷Qazvin, Iran, Islamic Republic of
Outpatient Pediatric Clinic
🇮🇷Qazvin, Iran, Islamic Republic of
Department of Public Health, Qazvin University of Medical Sciences
🇮🇷Qazvin, Iran, Islamic Republic of